covid vaccine and semaglutide Weight-loss drug tied to lower risk of death from COVID, heart disease, all causes Analysis of 25 studies shows

Eli Lilly, Novo Nordisk expand operations amid GLP-1 drug boom Biopharma bigwigs Eli Lilly and Novo Nordisk are upping capacity to meet the rising demands of GLP-1 drugs

FDAs 503B bulks list identifies drug substances that outsourcing facilities can use to compound medications

This year, Koreas cohort is not just seeking meetings -- they are determined to convert discussions into tangible partnerships and deals

adults have a currently approved medical indication for semaglutide

The recommended starting dose is 0.25 mg per day, and the dose is slowly increased over four weeks until it reaches the maintenance dose

& Ali, M